Business / Finance

RSS

H&P Labs announces licensing agreement to develop oral drug therapy against Ebola

H&P Labs Inc. announced an agreement with Harvard University and Brigham and Women's Hospital to license two classes of compounds in order to develop an oral drug therapy against Ebola.

8 Jan 2015

Helsinn, Pharmacosmos sign license agreement for commercialization of Monofer in the US

Helsinn Group and Pharmacosmos A/S today jointly announce that they have entered into an agreement for the exclusive US commercialization rights to Monofer, an innovative intravenous iron replacement therapy under development for the treatment of Iron Deficiency Anemia.

8 Jan 2015

Sciformix opens new European office in Manchester, UK

Sciformix Corporation, a leading Scientific Process Organization, has opened a new office in Manchester, UK expanding its global presence and footprint to include the European region.

8 Jan 2015

Carl Zeiss Meditec to invest in Oraya Therapy for treatment of wet AMD

Carl Zeiss Meditec AG and Oraya Therapeutics, Inc. jointly announced today that the companies have entered into a collaboration agreement under which Carl Zeiss Meditec will provide funding to Oraya over a period of up to two years for the implementation of Oraya’s growth strategy, and in turn receive rights in the company reaching up to a majority stake after two years.

8 Jan 2015

Ferrer partners with Cipher Pharmaceuticals to bring Ozenoxacin to the Canadian market

Ferrer, a privately-held Spanish pharmaceutical company, today announces that it has licensed commercialisation rights for Ozenoxacin one per cent cream in Canada to Cipher Pharmaceuticals Inc.

8 Jan 2015

Kyowa Hakko Kirin and Syndax sign agreement to develop entinostat in Japan and Korea

Kyowa Hakko Kirin Co., Ltd., (Headquarters: Chiyoda-ku, Tokyo; president and CEO: Nobuo Hanai, "Kyowa Hakko Kirin") and Syndax Pharmaceuticals, Inc., (Waltham, Mass.; president and CEO: Arlene M. Morris, "Syndax") today jointly announced that the companies have entered into a license agreement for the exclusive rights to develop and commercialize entinostat in Japan and Korea.

7 Jan 2015

CareSouth Health System to commence national rebranding of CareSouth agencies

CareSouth Health System, Inc., a national senior living services provider based in Augusta, Ga., announced today that it will begin a national rebranding of its CareSouth agencies across all CareSouth branded business lines including CareSouth Home Health, CareSouth Hospice, CareSouth Private Duty and CS Health & Wellness.

7 Jan 2015

LSNE's Harvey Road facility receives approval to manufacture drug product for US distribution

Lyophilization Services of New England, Inc. announced today that following an FDA Pre-Approval Inspection (PAI) in November 2014, their Harvey Road manufacturing site has received approval to manufacture commercial drug product for US distribution.

7 Jan 2015

EnGeneIC closes oversubscribed Series B financing

EnGeneIC, Ltd., an emerging biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of cancer therapeutics, announced it has completed an oversubscribed $10 million Series B financing.

6 Jan 2015

Elsevier assumes publication of Neoplasia and Translational Oncology journals

Elsevier, a world-leading provider of scientific, technical and medical information products and solutions, has announced that it has acquired Neoplasia Press Inc. and assumes publication of its flagship journals, Neoplasia and Translational Oncology. These peer-reviewed, open access journals are now published by Elsevier under the Neoplasia Press imprint.

6 Jan 2015

Oncoceutics, MD Anderson partner to develop novel anti-cancer drug

Oncoceutics Inc. and The University of Texas MD Anderson Cancer Center today announced the initiation of a strategic alliance and research collaboration agreement for the clinical development of ONC201, a novel anti-cancer drug.

5 Jan 2015

Clementia secures additional $10 million to support development of palovarotene for treatment of FOP

Clementia Pharmaceuticals, Inc. today announced that it has secured an additional $10 million from current investors to support development of the company's lead compound palovarotene for the treatment of fibrodysplasia ossificans progressive (FOP).

5 Jan 2015

Catamaran acquires Salveo Specialty Pharmacy for $260 million

Catamaran Corp., a leading provider of pharmacy benefit management (PBM) services and technology solutions, announced today the completion, effective as of January 2, 2015, of its previously disclosed acquisition of Salveo Specialty Pharmacy, for a purchase price of $260 million in cash, subject to certain customary post-closing adjustments.

5 Jan 2015

Jopari Solutions, Noble House partner to advance medical billing and processing

Jopari Solutions, the principal supplier of medical EDI services and connectivity networks to Providers and Payers in Property & Casualty markets, and Noble House, a software leader for billing and claims management for DME/HME, today announced a strategic partnership to advance medical billing and processing.

5 Jan 2015

TxCell announces further enhancement to development of Ovasave for IBD treatment

Paulsen Foundation to provide specialist management and scientific and development expertise that is dedicated to advanced therapies, i.e. cellular and gene therapies. This new class of highly promising biological therapies includes TxCell’s Ovasave.

5 Jan 2015

Spark Therapeutics files Form S-1 registration statement for initial public offering of common stock

Spark Therapeutics announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock.

2 Jan 2015

Mimedx receives subpoena from Office of Inspector General, HHS

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today that it has received a subpoena from the Office of Inspector General ("OIG") of the Department of Health and Human Services ("HHS") in connection with a civil investigation into matters primarily related to the Company's sales and marketing activities.

2 Jan 2015

Elements Behavioral Health acquires Park Bench Group Counseling

Elements Behavioral Health, a leading nationwide provider of addiction and mental health treatment programs, announced today that it has acquired Park Bench Group Counseling, located in Southeastern New Jersey.

31 Dec 2014

OncoGenex executes initial agreement with Teva to regain rights to custirsen

OncoGenex Pharmaceuticals, Inc. today announced that it has executed an initial agreement with Teva Pharmaceutical Industries Ltd. to regain rights to custirsen, an investigational compound currently being evaluated in Phase 3 clinical development as a treatment for prostate and lung cancers.

31 Dec 2014

Lightpoint Medical raises $3.1M in Series A financing round for medical imaging technology

Lightpoint Medical, a developer of innovative surgical imaging technologies, announced today that the company has raised £2 million ($3.1 million) in a Series A financing round.

31 Dec 2014

Business / Finance

H&P Labs announces licensing agreement to develop oral drug therapy against Ebola

Helsinn, Pharmacosmos sign license agreement for commercialization of Monofer in the US

Sciformix opens new European office in Manchester, UK

Carl Zeiss Meditec to invest in Oraya Therapy for treatment of wet AMD

Ferrer partners with Cipher Pharmaceuticals to bring Ozenoxacin to the Canadian market

Kyowa Hakko Kirin and Syndax sign agreement to develop entinostat in Japan and Korea

CareSouth Health System to commence national rebranding of CareSouth agencies

LSNE's Harvey Road facility receives approval to manufacture drug product for US distribution

EnGeneIC closes oversubscribed Series B financing

Elsevier assumes publication of Neoplasia and Translational Oncology journals

Oncoceutics, MD Anderson partner to develop novel anti-cancer drug

Clementia secures additional $10 million to support development of palovarotene for treatment of FOP

Catamaran acquires Salveo Specialty Pharmacy for $260 million

Jopari Solutions, Noble House partner to advance medical billing and processing

TxCell announces further enhancement to development of Ovasave for IBD treatment

Spark Therapeutics files Form S-1 registration statement for initial public offering of common stock

Mimedx receives subpoena from Office of Inspector General, HHS

Elements Behavioral Health acquires Park Bench Group Counseling

OncoGenex executes initial agreement with Teva to regain rights to custirsen

Lightpoint Medical raises $3.1M in Series A financing round for medical imaging technology

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Latest News